Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-07-30 2019-06-28
Drug Identification Number 02424878 02424878
Brand name PMS-BUPRENORPHINE-NALOXONE PMS-BUPRENORPHINE-NALOXONE
Common or Proper name BUPRENORPHINE-NALOXONE BUPRENORPHINE-NALOXONE
Company Name PHARMASCIENCE INC PHARMASCIENCE INC
Ingredients BUPRENORPHINE NALOXONE BUPRENORPHINE NALOXONE
Strength(s) 8MG 2MG 8MG 2MG
Dosage form(s) TABLET TABLET
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size 30 30
ATC code N07BC N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-06-27 2019-06-27
Estimated end date 2019-07-29 2019-07-29
Actual end date 2019-07-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments